The purpose of this study is to investigate the effect of semaglutide in women with Polycystic Ovarian Syndrome(PCOS ) and determine potential therapeutic benefits.
The study mainly focused for the following objectives: To determine the effect of semaglutide on ovulation and menstrual regularity. To determine the effect of semaglutide on androgen levels, namely testosterone, sex hormone binding globulin, and changes in hirsutism. To determine changes in weight, body mass index (BMI), and Glycated Hemoglobin( HbA1c) with semaglutide therapy.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
effectiveness of semaglutide in PCOS
Number of appropriate weekly dose
To access the compliances of the therapy
Time frame: 4 weeks
Number of days on therapy
To access the persistence on Semaglutide
Time frame: 4 weeks
measure the Weight in kilograms
To access the weight changes during therapy
Time frame: 4 weeks
Numbers of days with exercise changes
To access the ability to do exercise during the therapy
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.